MARISSA HULME: Open Payments
NPI 1518620475 · DUBUQUE, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$525 in 30 payments from 15 companies in 2025. Trend: 2023 $200 · 2024 $524 · 2025 $525
Food & beverage: $525
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 5 | $74 |
| ABBVIE INC. | 3 | $69 |
| Novo Nordisk Inc | 3 | $61 |
| Dexcom, Inc. | 3 | $57 |
| GlaxoSmithKline, LLC. | 3 | $51 |
| Sequel Med Tech, LLC | 2 | $42 |
| Tandem Diabetes Care, Inc. | 2 | $30 |
| Astellas Pharma US Inc | 1 | $23 |
| Medtronic, Inc. | 1 | $19 |
| Radius Health, Inc. | 1 | $19 |
Products named: VRAYLAR, OTEZLA, Dexcom G6 Transmitter, SHINGRIX, TWIIST, Ozempic, t:slim X2 Insulin Pump with Control-IQ, Wegovy.
Industry payments across IA — which companies pay providers there.
